Table 1.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Sex (female = 1) | 1 | |||||||||||||
2. Age at T1 sample | −0.35*** | 1 | ||||||||||||
3. T1–T2 interval | 0.17 | −0.10 | 1 | |||||||||||
4. ELS | 0.02 | −0.06 | −0.00 | 1 | ||||||||||
5. L CMA | −0.16* | 0.12 | −0.05 | 0.09 | 1 | |||||||||
6. R CMA | −0.03 | 0.08 | −0.05 | 0.19* | .49*** | 1 | ||||||||
7. L BLA | 0.02 | 0.06 | −0.11 | 0.12 | 0.28*** | −0.06 | 1 | |||||||
8. R BLA | 0.00 | 0.10 | −0.04 | 0.13 | 0.41*** | 0.37*** | 0.43*** | 1 | ||||||
9. L CMA–vmPFC | 0.04 | 0.00 | −0.10 | −0.20* | 0.01 | −0.12 | −0.05 | −0.12 | 1 | |||||
10. R CMA–vmPFC | 0.01 | 0.12 | −0.26* | −0.32*** | 0.03 | −0.14 | 0.16 | 0.04 | 0.49*** | 1 | ||||
11. L BLA–vmPFC | −0.09 | 0.03 | 0.11 | −0.08 | 0.14 | 0.05 | 0.05 | −0.03 | 0.17* | 0.21** | 1 | |||
12. R BLA–vmPFC | −0.06 | −0.03 | 0.19 | 0.06 | 0.09 | 0.03 | −0.07 | 0.03 | 0.36*** | 0.19* | 0.41*** | 1 | ||
13. TL change | 0.01 | −0.04 | 0.11 | −0.12 | −0.10 | −0.19* | −0.10 | −0.09 | −0.26** | −0.17 | −0.10 | 1 | ||
14. Pubertal tempo | −0.06 | 0.28*** | 0.13 | −0.07 | 0.09 | 0.03 | 0.12 | 0.06 | −0.03 | 0.01 | 0.23* | −0.11 | 1 | |
Mean or % | 57% | 11.38 | 1.97 | 6.96 | 0.07 | 0.19 | −0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | −0.05 | 0.70 |
SD | 1.04 | 0.34 | 5.44 | 0.75 | 0.67 | 0.87 | 0.95 | 0.10 | 0.09 | 0.09 | 0.09 | 0.10 | 0.43 |
Note: ***P < 0.001, **P < 0.01, *P < 0.05. ELS = early life stress; CMA = centromedial amygdala; BLA = basolateral amygdala; T1 = Time 1; T2 = Time 2; L = left; R = right; TL change = (T2 telomere length minus T1 telomere length)/T1–T2 interval; Pubertal tempo = T2 Tanner stage minus T1 Tanner stage)/T1–T2 interval. All correlations with TL change and pubertal tempo controlled for T1 telomere length and T1 Tanner stage, respectively.